A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907).
about
The role of induction therapyPreoperative therapy in locally advanced esophageal cancerReevaluation of Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma: A Meta-Analysis of Randomized Controlled Trials Over the Past 20 YearsCurrent Status and Future Prospects for Esophageal Cancer TreatmentCurrent Advancement in Multidisciplinary Treatment for Resectable cStage II/III Esophageal Squamous Cell Carcinoma in Japan.Postoperative radiation therapy of pT2-3N0M0 esophageal carcinoma-a review.Variations in survival and perioperative complications between hospitals based on data from two phase III clinical trials for oesophageal cancer.Phase I/II trial of chemoradiotherapy with concurrent S-1 and cisplatin for clinical stage II/III esophageal carcinoma (JCOG 0604)Expression and role of anion exchanger 1 in esophageal squamous cell carcinomaSevere neutrophilic leukocytosis as a progression marker in granulocyte colony-stimulating factor-producing squamous cell carcinoma of the esophagus.Survival comparison between radical surgery and definitive chemoradiation in 267 esophageal squamous cell carcinomas in a single institution: A propensity-matched study.Enhanced cancer stem cell properties of a mitotically quiescent subpopulation of p75NTR-positive cells in esophageal squamous cell carcinoma.CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamouCurrent status of predictive biomarkers for neoadjuvant therapy in esophageal cancerRPN2 expression predicts response to docetaxel in oesophageal squamous cell carcinoma.Lymph node enlargement after definitive chemoradiotherapy for clinical stage I esophageal squamous cell carcinomaThe oncoprotein and stem cell renewal factor BMI1 associates with poor clinical outcome in oesophageal cancer patients undergoing preoperative chemoradiotherapyZNF695 methylation predicts a response of esophageal squamous cell carcinoma to definitive chemoradiotherapy.Perioperative therapy for esophageal cancer.Adjuvant chemotherapy versus surgery alone for esophageal squamous cell carcinoma: a meta-analysis of randomized controlled trials and nonrandomized studies.Multimodality management of esophageal cancer.Effect of ECRG2 in combination with cisplatin on the proliferation and apoptosis of EC9706 cells.A New Candidate Supporting Drug, Rikkunshito, for the QOL in Advanced Esophageal Cancer Patients with Chemotherapy Using Docetaxel/5-FU/CDDP.Comprehensive screening of genes resistant to an anticancer drug in esophageal squamous cell carcinomaPhase I/II trial of 2-weekly docetaxel combined with cisplatin plus fluorouracil in metastatic esophageal cancer (JCOG0807).Long-term results of chemoradiotherapy for stage II-III thoracic esophageal cancer in a single institution after 2000 -with a focus on comparison of three protocolsOverexpression of PFTK1 predicts resistance to chemotherapy in patients with oesophageal squamous cell carcinoma.Discovery of a Good Responder Subtype of Esophageal Squamous Cell Carcinoma with Cytotoxic T-Lymphocyte Signatures Activated by ChemoradiotherapyCXCR2 expression and postoperative complications affect long-term survival in patients with esophageal cancer.Locally advanced cancer of the esophagus, current treatment strategies, and future directionsMultidisciplinary therapy for granulocyte-colony-stimulating factor producing carcinosarcoma of the esophagus: report of a case.CXCL12 expression promotes esophageal squamous cell carcinoma proliferation and worsens the prognosisPhase I Dose-Escalation Study of Docetaxel, Cisplatin, and 5-Fluorouracil Combination Chemotherapy in Patients With Advanced Esophageal CarcinomaThe pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study.Outcome of neoadjuvant therapies for cancer of the oesophagus or gastro-oesophageal junction based on a national data registry.The Impact of Postoperative Complications on Survivals After Esophagectomy for Esophageal Cancer.Perineural invasion correlates with postoperative distant metastasis and poor overall survival in patients with PT1-3N0M0 esophageal squamous cell carcinoma.The efficacy and toxicities of combined lobaplatin with paclitaxel as a first-line chemotherapy for advanced esophageal squamous cell carcinoma.Update on Neoadjuvant Regimens for Patients with Operable Oesophageal/Gastrooesophageal Junction Adenocarcinomas and Squamous Cell CarcinomasLaparoscopic jejunostomy for obstructing upper gastrointestinal malignancies
P2860
Q26830698-6205656F-92A6-4B61-8D4B-10C9BBED157FQ28070310-B9CA04AB-2B3F-4A53-B094-72A571FC3740Q28081365-2074BD15-3D15-4DE4-9F88-DF17B469657CQ30240008-B43429D5-266B-40A3-AF84-6A799EB9C34EQ30244382-1503AD7F-A70D-4990-A129-C2DE2C7098E6Q30245279-0E9897A1-6675-48FB-AC5E-D1E209B058CCQ30975636-1B75BAF0-97C4-4ACB-8097-054AB0D24FA2Q33424985-8379EEB3-6270-4128-83B2-37B86FAF11DDQ33566741-3510C296-E2A6-4BF9-AB9B-80C12C549DC6Q33625881-3F9AF695-0875-4DCF-AB6F-42FFD1DDD2ADQ33653046-1DDF9A28-B439-4D56-981B-AA6BB9F8BE37Q33788010-E63D1272-7523-4DB8-A35F-1F89DD9AD615Q33850915-E7AE952C-2F70-4B97-B5D9-2B7E6CB860FCQ34048027-6478A92A-6B5C-44A1-BAC5-CEFB39D82EC4Q34298027-85AF59B9-A6B6-4345-8F7A-D7CC8D1C7217Q34320528-DA8C8178-82DA-4EEC-A4BF-1E9D2A97BF5BQ34436695-9E8C0374-CCAC-476F-92BE-D4D6A158D7F4Q34441327-2EA530A1-FCB8-4FAB-BD3E-58BE9270FD3AQ34663544-A0E11A98-DEE9-4936-B69A-22C0373F03ACQ34689864-B1D0C8AC-6146-49FD-ADDA-E71255A1BD3EQ34981111-A975CB26-81C9-48B6-8D3F-9AF8118127F0Q35307690-405F075D-A0A9-4743-B5AE-3F5A50772585Q35687667-93546412-EF2D-490A-9BCD-4130B90198C3Q35707383-EAFE599B-8EA4-457C-8033-382906053955Q35713647-A86A621F-4B84-4000-8090-404A329E8AC7Q35823373-21CB6702-F304-4581-BE68-B408A3EA4D70Q35835123-99CD727C-4A82-4327-9091-D08D952C5DE1Q35857352-A18DD0D1-5A36-467E-886F-344CA068BB99Q35908232-FEAC7593-29AD-464F-82A9-7785F20071C9Q35985417-C0DCC3EA-661B-4C36-BFBC-6CD89395C3F4Q36000749-0AEBF2BD-6DF6-4027-94B2-E0C0C30093C2Q36083316-267F9DC3-31A3-41AF-8958-91DD9B3C05C8Q36104323-1F3703B0-5195-4629-B1D8-543B2E53F3B7Q36124168-FD8C7844-212A-44F3-97EF-DDB1E9ABE8BFQ36149779-FABA4102-6B6E-4D67-9991-9E13D1435EADQ36194108-3147CE35-84F6-47DD-B316-532720BBEADFQ36239987-9D90E34E-B075-4908-8C26-2401E192AACCQ36254407-461479B6-4453-43D5-B502-0A8B58BD3B9EQ36284695-56146D40-C9E4-426D-BCBD-E675E3877F39Q36334545-E84F644B-6D68-488E-A163-FBE3742A9A2E
P2860
A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907).
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
A randomized trial comparing p ...... thoracic esophagus (JCOG9907).
@en
A randomized trial comparing p ...... noma of the thoracic esophagus
@nl
type
label
A randomized trial comparing p ...... thoracic esophagus (JCOG9907).
@en
A randomized trial comparing p ...... noma of the thoracic esophagus
@nl
prefLabel
A randomized trial comparing p ...... thoracic esophagus (JCOG9907).
@en
A randomized trial comparing p ...... noma of the thoracic esophagus
@nl
P2093
P1476
A randomized trial comparing p ...... thoracic esophagus (JCOG9907).
@en
P2093
Akira Kurita
Haruhiko Fukuda
Hideaki Shimizu
Hiroshi Yabusaki
Hiroyasu Igaki
Hoichi Kato
Kenichi Nakamura
Kenichiro Ikeda
Masayuki Shinoda
Nobutoshi Ando
P2888
P356
10.1245/S10434-011-2049-9
P577
2011-08-31T00:00:00Z
P5875
P6179
1010098383